Search research articles
Contact Us
Filters
Showing results (31-40 of 88) with videos related to
Page
of 9
Sort By:
Infectious Disease Modelling
|
June 22, 2018
Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in <i>Plasmodium falciparum</i>
Aleisha R Brock, Joshua V Ross, Scott Greenhalgh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 25, 2012
Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers
Liusheng Huang, Sunil Parikh, Philip J Rosenthal, et al.
Emerging Infectious Diseases
|
July 20, 2016
Asymptomatic Plasmodium Infections in Children in Low Malaria Transmission Setting, Southwestern Uganda(1)
Michelle E Roh, Caesar Oyet, Patrick Orikiriza, et al.
Infection and Immunity
|
October 1, 2008
Experimental malaria infection triggers early expansion of natural killer cells
Charles C Kim, Sunil Parikh, Joseph C Sun, et al.
The American Journal of Tropical Medicine and Hygiene
|
September 28, 2016
Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda
Michelle E Roh, Caesar Oyet, Patrick Orikiriza, et al.
Malaria Journal
|
November 9, 2017
Evaluation of the Deki Reader™, an automated RDT reader and data management device, in a household survey setting in low malaria endemic southwestern Uganda
Caesar Oyet, Michelle E Roh, Gertrude N Kiwanuka, et al.
Clinical Trials (London, England)
|
July 5, 2021
Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data
Conner L Jackson, Kathryn Colborn, Dexiang Gao, et al.
BMC Infectious Diseases
|
June 28, 2019
Comparison on simultaneous caillary and venous parasite density and genotyping results from children and adults with uncomplicated malaria: a prospective observational study in Uganda
Aine Lehane, Moses Were, Martina Wade, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 10, 2009
Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers
Polina German, Sunil Parikh, Jody Lawrence, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 14, 2020
Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women
Emma Hughes, Norah Mwebaza, Liusheng Huang, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 88) with videos related to
Sort By:
Page
of 9
Infectious Disease Modelling
|
June 22, 2018
Modelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance in <i>Plasmodium falciparum</i>
Aleisha R Brock, Joshua V Ross, Scott Greenhalgh, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 25, 2012
Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers
Liusheng Huang, Sunil Parikh, Philip J Rosenthal, et al.
Emerging Infectious Diseases
|
July 20, 2016
Asymptomatic Plasmodium Infections in Children in Low Malaria Transmission Setting, Southwestern Uganda(1)
Michelle E Roh, Caesar Oyet, Patrick Orikiriza, et al.
Infection and Immunity
|
October 1, 2008
Experimental malaria infection triggers early expansion of natural killer cells
Charles C Kim, Sunil Parikh, Joseph C Sun, et al.
The American Journal of Tropical Medicine and Hygiene
|
September 28, 2016
Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda
Michelle E Roh, Caesar Oyet, Patrick Orikiriza, et al.
Malaria Journal
|
November 9, 2017
Evaluation of the Deki Reader™, an automated RDT reader and data management device, in a household survey setting in low malaria endemic southwestern Uganda
Caesar Oyet, Michelle E Roh, Gertrude N Kiwanuka, et al.
Clinical Trials (London, England)
|
July 5, 2021
Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data
Conner L Jackson, Kathryn Colborn, Dexiang Gao, et al.
BMC Infectious Diseases
|
June 28, 2019
Comparison on simultaneous caillary and venous parasite density and genotyping results from children and adults with uncomplicated malaria: a prospective observational study in Uganda
Aine Lehane, Moses Were, Martina Wade, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 10, 2009
Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers
Polina German, Sunil Parikh, Jody Lawrence, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 14, 2020
Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women
Emma Hughes, Norah Mwebaza, Liusheng Huang, et al.
Page
of 9